To evaluate if Tyrobp deletion modulates pathways selectively activated in HD human brains which may not be dysregulated in the mouse, we took advantage of previously published pathway analysis performed on transcriptomic data obtained from HD human presymptomatic caudate, and symptomatic and presymptomatic cortex [15]. This evidence concerns the gene TYROBP and Huntington disease.